Prediction of Cognitive Properties of Memantine for Neurodegenerative Diseases

Summary

The early assessment of new drugs for Alzheimer's disease remains difficult because of the lack of predictive end-point. The use of a battery including different parameters could improve this early development of new drugs. Nevertheless, the interest of such a battery should previously be validated with the yet marketed AD drugs.

Timeline

Start

2016-09-14

Primary completion

2020-12-31

Completion

2020-12-31

Drugs

Indications